Kyle LaHucik, an associate editor covering the gamut of the biotech industry for Endpoints News, has taken on the role of senior reporter to cover venture capital funding, M&A, IPOs and company creation for the financing and business development side of biopharma.
Prior to joining Endpoints, LaHucik was a staff writer at FierceMarkets. Before that, he was a reporter at Mergermarket and interned at Bloomberg, Bloomberg BNA and MLex Market Insight. He was also a newsletter writer at Missouri Business Alert.
He also worked as a public life reporter and education reporter at Columbia Missourian.
LaHucik has a bachelor’s degree in journalism from the University of Missouri-Columbia.
You can congratulate LaHucik on X/Twitter.
The Wall Street Journal is looking for an editor to lead its coverage of logistics…
The Wall Street Journal seeks an enterprising and ambitious reporter to cover the intersection of…
The Wall Street Journal is seeking a reporter in Washington, DC, to chronicle one of…
Reuters has hired Wall Street Journal reporter Anna Hirtenstein. She will start next month. Hirtenstein has…
Caroline Gage, head of the Americas for Bloomberg News, sent the following announcement to staff:…
Forbes senior editor Amy Feldman is now covering health care. She had been covering industrial innovation and…